Heartflow, Inc.

Name: Heartflow, Inc. standardized financial statements, quarterly
Creator: Listed

HTFLNasdaqCIK 1464521HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$64.1m, Q2 FY2026

Operating income−$17.9m, Q2 FY2026

Net income−$15.7m, Q2 FY2026

Heartflow, Inc., income statement, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	not reported	31.1	32.9	35.0	37.2	43.4	46.3	49.1	52.6	64.1
Cost of revenue	$m	not reported	7.2	8.0	8.7	9.3	10.6	10.9	10.1	10.4	10.9
Gross profit	$m	not reported	23.8	24.9	26.3	27.9	32.8	35.4	39.1	42.2	53.2
Research and development	$m	not reported	9.9	11.9	12.3	13.9	15.0	17.3	18.7	21.6	26.3
Selling, general and administrative	$m	not reported	28.1	28.0	30.0	31.5	31.5	33.2	38.1	42.6	44.8
Operating income	$m	not reported	(14.2)	(14.9)	(16.1)	(17.5)	(13.7)	(15.1)	(17.8)	(29.5)	(17.9)
Interest expense	$m	not reported	6.1	5.3	5.2	5.1	6.6	3.5	0.0	0.0	0.0
Income tax	$m	not reported	0.1	0.0	0.0	not reported	0.1	0.0	(0.2)	0.0	0.0
Net income	$m	(20.9)	(23.4)	(19.1)	(33.0)	(32.3)	(9.2)	(50.9)	(24.4)	(27.4)	(15.7)
Diluted EPS	$ per share	not reported	(4.66)	(3.43)	not reported	(5.25)	(1.46)	(1.04)	not reported	(0.32)	(0.18)
Basic EPS	$ per share	not reported	(4.66)	(3.43)	not reported	(5.25)	(1.46)	(1.04)	not reported	(0.32)	(0.18)

Balance sheet

Cash and equivalents$34.4m, Q2 FY2026

Shareholders' equity$279.7m, Q2 FY2026

Heartflow, Inc., balance sheet, quarterly
Line item	Unit	period not labelled2022-12-31	period not labelled2023-12-31	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	not reported	123	not reported	75.4	64.7	51.4	110	80.2	291	44.8	19.7	34.4
Current assets	$m	not reported	not reported	not reported	not reported	not reported	82.3	not reported	118	328	220	212	224
Total assets	$m	not reported	not reported	not reported	not reported	not reported	119	not reported	159	364	359	344	344
Current liabilities	$m	not reported	not reported	not reported	not reported	not reported	33.6	not reported	32.9	37.8	42.4	38.0	44.1
Total liabilities	$m	not reported	not reported	not reported	not reported	not reported	210	not reported	286	110	58.8	58.3	64.7
Shareholders' equity	$m	(694)	(778)	(796)	(815)	(831)	(859)	(889)	(895)	255	301	286	280

Cash flow

Operating cash flow−$8.6m, Q2 FY2026

Capital expenditure$1.9m, Q2 FY2026

Heartflow, Inc., cash flow, quarterly
Line item	Unit	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	(10.3)	(14.0)	(13.2)	(27.3)	(3.0)	(10.6)	(30.1)	(8.6)
Capital expenditure	$m	1.0	0.3	1.1	0.8	1.2	1.9	1.9	1.9

Diluted shares (weighted)86.40m, Q2 FY2026

Heartflow, Inc., shares, quarterly
Line item	Unit	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	5.0	5.6	6.2	6.3	49.1	85.6	86.4

Shares outstanding: 86.95m at Jul 31, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.